Supporting the goals and ideals of "Deep Vein Thrombosis and Pulmonary Embolism Awareness Month".
Impact
The resolution points out alarming statistics regarding DVT and PE, indicating that between 60,000 to 100,000 individuals die annually as a result of these conditions, many of which are preventable. It also notes that around 900,000 individuals are affected each year, leading to substantial medical costs estimated at up to $10 billion. By promoting awareness, the bill aims to facilitate education around prevention strategies and the importance of seeking medical attention, particularly for at-risk populations such as cancer patients and pregnant women.
Summary
HR1112 is a resolution that supports the establishment of March as 'Deep Vein Thrombosis and Pulmonary Embolism Awareness Month.' The resolution highlights the serious health risks associated with Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), with DVT being a condition where blood clots form in the deep veins, while PE is a life-threatening complication where these clots travel to the lungs. The bill emphasizes the importance of increased awareness about these often preventable conditions, which significantly impact health outcomes in the United States.
Contention
While the bill is largely supportive and aims to encourage the recognition of March as a month dedicated to awareness, it does not delve into the complexities of healthcare policies and funding associated with DVT and PE treatment. Some may argue that more concrete legislative actions are needed beyond awareness to address the healthcare system's capabilities in handling DVT and PE cases effectively. Furthermore, advocates for health reform might contend that mere awareness without the support of prevention programs and healthcare accessibility will not suffice to address the significant morbidity and mortality rates associated with these conditions.